Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06070272

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Clinical studies, with a dedicated focus on recurrent prostate cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition.

These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to endorse their broader utilization.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future patients with recurrent prostate cancer.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Recurrent Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient is at least 18 years of age
  • Diagnosis of recurrent prostate cancer
  • Ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

  • Enrolled in another research study
  • Patients with psychiatric illness/social situations that would limit compliance with study requirements
  • Inability to provide written informed consent

Treatment and study plan

Primary outcomes

  1. Number of patients who decide to participate in a recurrent prostate cancer clinical research

    Time frame: 3 months

  2. Rate of patients who remain in recurrent prostate cancer clinical research to trial completion

    Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

4159004227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Investigating the Dynamics of Patient Engagement and Trends in Participation in Recurrent Prostate Cancer Clinical Trials

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Oct 6, 2023
Registry last updated
Oct 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.